the sertindole safety survey a retrospective analysis under a named patient use programme in europesertindole安全调查一个回顾性分析在一个名叫病人使用计划在欧洲.pdfVIP

BMC Psychiatry BioMed Central Research article Open Access The Sertindole Safety Survey: A retrospective analysis under a named patient use programme in Europe 1 2 3 Christophe Lançon , Mondher Toumi , Christophe Sapin and Karina Hansen*3 Address: 1Département de Psychiatrie, CHU Sainte Marguerite, Marseilles, France, 2Université de Lyon I, Lyon, France and 3H. Lundbeck A/S, Paris, France Email: Christophe Lançon - christophe.lancon@mail.ap-hm.fr; Mondher Toumi - mto@; Christophe Sapin - chsa@; Karina Hansen* - khan@ * Corresponding author Published: 18 July 2008 Received: 21 January 2008 Accepted: 18 July 2008 BMC Psychiatry 2008, 8:57 doi:10.1186/1471-244X-8-57 This article is available from: /1471-244X/8/57 © 2008 Lançon et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Background: After sertindoles suspension, health authorities established a specific named-patient use (NPU) programme in order to supply sertindole to patients who did not respond to or did not tolerate alternative treatments. This programme provided the possibility of prospectively following an exhaustive cohort of patients treated with sertindole after its suspension. A su